Please use this identifier to cite or link to this item:
Title: Correction : Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine : pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
Author(s): Nahas, Stephanie J.
Naegel, Steffen
Cohen, Joshua M.
Ning, Xiaoping
Janka, Lindsay
Ramirez Campos, Verena
Krasenbaum, Lynda J.
Holle-Lee, Dagny
Kudrow, David
Lampl, Christian
Issue Date: 2022
Type: Article
Language: English
Open Access: Open access publication
License: (CC BY 4.0) Creative Commons Attribution 4.0(CC BY 4.0) Creative Commons Attribution 4.0
Sponsor/Funder: Publikationsfonds MLU
Journal Title: The journal of headache and pain
Publisher: Springer Italia
Publisher Place: Milano
Volume: 23
Original Publication: 10.1186/s10194-022-01423-x
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
s10194-022-01423-x.pdf1.11 MBAdobe PDFThumbnail